Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Commun (Camb) ; 57(10): 1190-1193, 2021 Feb 04.
Article in English | MEDLINE | ID: mdl-33448267

ABSTRACT

The use of aminals in dynamic covalent chemistry is slightly underexplored, probably due to their inherent instability. Here we report the spontaneous [2+2] macrocyclization of tetrakis(aminals). Their unexpected stability and structural modularity, the dynamic nature of the connections and their water tolerance make them appealing systems for future applications as stimulus-responsive materials.

2.
Biosens Bioelectron ; 66: 115-23, 2015 Apr 15.
Article in English | MEDLINE | ID: mdl-25460891

ABSTRACT

A label-free biosensing strategy for amoxicillin (AX) allergy diagnosis based on the combination of novel dendrimer-based conjugates and a recently developed nanoplasmonic sensor technology is reported. Gold nanodisks were functionalized with a custom-designed thiol-ending-polyamido-based dendron (d-BAPAD) peripherally decorated with amoxicilloyl (AXO) groups (d-BAPAD-AXO) in order to detect specific IgE generated in patient's serum against this antibiotic during an allergy outbreak. This innovative strategy, which follows a simple one-step immobilization procedure, shows exceptional results in terms of sensitivity and robustness, leading to a highly-reproducible and long-term stable surface which allows achieving extremely low limits of detection. Moreover, the viability of this biosensor approach to analyze human biological samples has been demonstrated by directly analyzing and quantifying specific anti-AX antibodies in patient's serum without any sample pretreatment. An excellent limit of detection (LoD) of 0.6ng/mL (i.e. 0.25kU/L) has been achieved in the evaluation of clinical samples evidencing the potential of our nanoplasmonic biosensor as an advanced diagnostic tool to quickly identify allergic patients. The results have been compared and validated with a conventional clinical immunofluorescence assay (ImmunoCAP test), confirming an excellent correlation between both techniques. The combination of a novel compact nanoplasmonic platform and a dendrimer-based strategy provides a highly sensitive label free biosensor approach with over two times better detectability than conventional SPR. Both the biosensor device and the carrier structure hold great potential in clinical diagnosis for biomarker analysis in whole serum samples and other human biological samples.


Subject(s)
Amoxicillin/immunology , Anti-Bacterial Agents/immunology , Drug Hypersensitivity/blood , Drug Hypersensitivity/diagnosis , Immunoglobulin E/blood , Surface Plasmon Resonance/instrumentation , Amoxicillin/adverse effects , Amoxicillin/chemistry , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/chemistry , Dendrimers/chemistry , Drug Hypersensitivity/immunology , Equipment Design , Gold/chemistry , Humans , Immunoglobulin E/immunology , Limit of Detection , Nanostructures/chemistry , Nylons/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...